Company Description
Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide.
It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.
The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products.
In addition, it is involved in the research and product development of skin care products and nutritional supplements.
Further, the company operates retail stores and service centers in Mainland China.
It sells its products under the Nu Skin, Pharmanex, and ageLOC brands.
The company promotes and sells its products directly, as well as through distributors and Website.
Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Country | United States |
IPO Date | Nov 22, 1996 |
Industry | Household & Personal Products |
Sector | Consumer Defensive |
Employees | 3,700 |
CEO | Ryan S. Napierski |
Contact Details
Address: 75 West Center Street Provo, Utah United States | |
Website | https://www.nuskin.com |
Stock Details
Ticker Symbol | NUS |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001021561 |
CUSIP Number | 67018T105 |
ISIN Number | US67018T1051 |
Employer ID | 87-0565309 |
SIC Code | 5122 |
Key Executives
Name | Position |
---|---|
Ryan S. Napierski | President, Chief Executive Officer & Director |
James D. Thomas | Executive Vice President, Chief Accounting Officer & Chief Financial Officer |
Joe Sueper | Senior Vice President & Chief Technology Officer |
Mark L. Adams | Chief Information Officer |
Blake M. Roney | Founder |
Chayce David Clark | Executive Vice President & General Counsel |
Dr. Joseph Y. Chang Ph.D. | Executive Vice President & Chief Scientific Officer |
Sandra N. Tillotson | Founder |
Steve Keith Hatchett | Executive Vice President & Chief Product Officer |
Steven J. Lund J.D. | Co-Founder & Executive Chairman of the Board |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 12, 2024 | 4 | Filing |
Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 08, 2024 | 10-Q | Quarterly Report |
Nov 07, 2024 | 8-K | Current Report |
Nov 06, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 04, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 01, 2024 | 8-K | Current Report |
Oct 18, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Sep 12, 2024 | 4 | Filing |
Sep 12, 2024 | 4 | Filing |